Latest Company Appointments News

Pro-Pac Packaging has entered voluntary administration, securing relief to defer its financial reporting and annual general meeting obligations for up to two years. This move pauses key corporate governance duties as the company navigates its restructuring.

Tesoro Gold has reported a significant 42% increase in its Ternera gold resource alongside a robust scoping study and a $34 million equity raise to accelerate development of its El Zorro project in Chile.

Many Peaks Minerals reports standout gold assay results from its Ferké and Odienné projects, alongside a strategic land acquisition and a A$13.5 million capital raise to fuel exploration.

Middle Island Resources has appointed Daniel Raihani as Non-Executive Chairman to steer the company through its pivotal acquisition of Serbian copper-gold assets.

Cyclone Metals has restructured its management, appointing Paul Berend as CEO of the Iron Bear Project while the Board temporarily oversees corporate functions during the search for a new CEO.

Singular Health Group reported a $6.38 million loss for FY2025 while securing a pivotal $1.3 million commercial agreement with US-based Provider Network Solutions to deploy its 3DICOM software. The company also completed a major cloud migration of its platform, positioning itself for growth in the US healthcare market.

Chimeric Therapeutics reported a reduced net loss of $10.43 million for FY2025, driven by cost efficiencies and strategic project reprioritisation, while making significant clinical progress in its CAR T-cell and NK cell therapy programs.

Coventry Group Ltd reported a 1.7% revenue decline and a 40.9% drop in EBITDA for FY25, prompting a major restructuring and a bullish FY26 earnings target above $20 million.

Linius Technologies reported a $5.31 million loss for FY25 as it shifts towards a sales-driven SaaS model, with new leadership and cost-cutting measures aiming to reshape its future.

Nanollose Limited reported a $1.43 million loss for FY2025 while progressing pilot production of innovative biomaterials and strengthening its balance sheet with a $2.1 million capital raise. The company appointed a new CEO to drive commercialisation efforts in FY2026.

Tabcorp Holdings Limited reported a robust FY25 with revenue climbing 11.8% and EBIT nearly doubling, driven by Victorian wagering licence reforms and disciplined cost management. The company’s strategic evolution and operational execution set the stage for modest growth in FY26.

Tabcorp Holdings Limited has reported a significant financial turnaround for FY25, driven by the new Victorian Wagering and Betting Licence and strategic operational improvements. The company posted $2.6 billion in revenue and a net profit after tax of $36.6 million, reversing last year's substantial loss.